Compare Brookfield Infrastructure Partners LP (BIP) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brookfield Infrastructure Partners LP vs Citius Pharmaceuticals Inc — how do they compare? Brookfield Infrastructure Partners LP trades at $39.85 (market cap $18.10B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Brookfield Infrastructure Partners LP is far larger — about 904.5× Citius Pharmaceuticals Inc's market cap, and Brookfield Infrastructure Partners LP pays a 4.62% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BIP | CTXR | |
|---|---|---|
Market Cap | $18.10B | $20.01M |
Sector | Industrials | Health |
52-Week High | $42.62 | $1.82 |
52-Week Low | $29.81 | $0.48 |
Enterprise Value | $77.05B | $16.23M |
Dividend Yield | 4.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brookfield Infrastructure Partners LP
Brookfield Infrastructure owns and operates high-quality global assets across utilities, transport, midstream, and data sectors. It focuses on generating stable, long-term cash flows from essential infrastructure.
Read more on BIP →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
